Susquehanna Fundamental Investments’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-192,563
| Closed | -$3.92M | – | 1117 |
|
|
2024
Q4 | $3.92M | Buy |
+192,563
| New | +$3.92M | 0.06% | 378 |
|
|
2024
Q2 | $5.18M | Buy |
222,917
+11,900
| +6% | +$276K | 0.12% | 226 |
|
|
2024
Q1 | $4.33M | Buy |
+211,017
| New | +$4.33M | 0.2% | 138 |
|
|
2023
Q4 | – | Sell |
-81,308
| Closed | -$1.68M | – | 145 |
|
|
2023
Q3 | $1.68M | Sell |
81,308
-9,941
| -11% | -$205K | 0.11% | 156 |
|
|
2023
Q2 | $2.69M | Hold |
91,249
| – | – | 0.1% | 213 |
|
|
2023
Q1 | $2.1M | Hold |
91,249
| – | – | 0.05% | 363 |
|
|
2022
Q4 | $2.54M | Buy |
+91,249
| New | +$2.54M | 0.04% | 428 |
|